QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
NASDAQ:OXBR

Oxbridge Re (OXBR) Stock Forecast, Price & News

$1.03
+0.03 (+3.00%)
(As of 09/21/2023 ET)
Compare
Today's Range
$0.97
$1.13
50-Day Range
$0.96
$1.89
52-Week Range
$0.96
$2.87
Volume
11,257 shs
Average Volume
18,056 shs
Market Capitalization
$6.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Oxbridge Re MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.84% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.35mentions of Oxbridge Re in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$33,553 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.77 out of 5 stars


OXBR stock logo

About Oxbridge Re (NASDAQ:OXBR) Stock

Oxbridge Re Holdings Limited, together with its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It distributes its products and solutions through reinsurance brokers. Oxbridge Re Holdings Limited was incorporated in 2013 and is headquartered in George Town, the Cayman Islands.

OXBR Price History

OXBR Stock News Headlines

Reviewing Oxbridge Re (NASDAQ:OXBR) and Root (NASDAQ:ROOT)
Fox Couldn't Air my #1 A.I. Pick - Get it Here.
50-year Wall Street Insider Marc Chaikin got invited onto Fox News to talk about A.I. - Here's what he couldn't say on television. More here.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
See More Headlines
Receive OXBR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxbridge Re and its competitors with MarketBeat's FREE daily newsletter.

OXBR Company Calendar

Last Earnings
8/14/2023
Today
9/21/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Fire, marine, & casualty insurance
Sub-Industry
N/A
Sector
Finance
Current Symbol
NASDAQ:OXBR
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Net Income
$-1,790,000.00
Pretax Margin
-84.88%

Debt

Sales & Book Value

Annual Sales
$850,000.00
Book Value
$2.59 per share

Miscellaneous

Free Float
4,833,000
Market Cap
$6.05 million
Optionable
Not Optionable
Beta
1.48
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Sanjay Madhu (Age 57)
    Chairman, Pres & CEO
    Comp: $290.31k
  • Mr. Wrendon Timothy (Age 43)
    CFO, Sec. & Director
    Comp: $167.31k
  • Dr. Reuel Ocho
    Head of Special Projects













OXBR Stock - Frequently Asked Questions

How have OXBR shares performed in 2023?

Oxbridge Re's stock was trading at $1.20 on January 1st, 2023. Since then, OXBR shares have decreased by 14.2% and is now trading at $1.03.
View the best growth stocks for 2023 here
.

Are investors shorting Oxbridge Re?

Oxbridge Re saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 38,800 shares, a decrease of 25.2% from the August 15th total of 51,900 shares. Based on an average daily trading volume, of 19,900 shares, the days-to-cover ratio is currently 1.9 days. Approximately 0.8% of the company's shares are short sold.
View Oxbridge Re's Short Interest
.

When is Oxbridge Re's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our OXBR earnings forecast
.

How were Oxbridge Re's earnings last quarter?

Oxbridge Re Holdings Limited (NASDAQ:OXBR) issued its quarterly earnings results on Monday, August, 14th. The insurance provider reported ($0.01) EPS for the quarter. The insurance provider had revenue of $0.69 million for the quarter.

What other stocks do shareholders of Oxbridge Re own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxbridge Re investors own include Bionano Genomics (BNGO), Organigram (OGI), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), Matinas BioPharma (MTNB), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI) and

What is Oxbridge Re's stock symbol?

Oxbridge Re trades on the NASDAQ under the ticker symbol "OXBR."

How do I buy shares of Oxbridge Re?

Shares of OXBR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Oxbridge Re's stock price today?

One share of OXBR stock can currently be purchased for approximately $1.03.

How much money does Oxbridge Re make?

Oxbridge Re (NASDAQ:OXBR) has a market capitalization of $6.05 million and generates $850,000.00 in revenue each year. The insurance provider earns $-1,790,000.00 in net income (profit) each year or ($0.24) on an earnings per share basis.

How can I contact Oxbridge Re?

Oxbridge Re's mailing address is SUITE 201 42 EDWARD STREET PO BOX 469, GEORGE TOWN E9, KY1-9006. The official website for the company is www.oxbridgere.com. The insurance provider can be reached via phone at (345) 749-7570.

This page (NASDAQ:OXBR) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -